The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.
about
Any Progress in the Treatment of Antibody-Mediated Rejection?Single Nucleotide Variant Counts Computed from RNA Sequencing and Cellular Traffic into Human Kidney Allografts.Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejectionDonor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
P2860
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The Banff 2017 Kidney Meeting ...... xt-generation clinical trials.
@en
The Banff 2017 Kidney Meeting ...... xt-generation clinical trials.
@nl
type
label
The Banff 2017 Kidney Meeting ...... xt-generation clinical trials.
@en
The Banff 2017 Kidney Meeting ...... xt-generation clinical trials.
@nl
prefLabel
The Banff 2017 Kidney Meeting ...... xt-generation clinical trials.
@en
The Banff 2017 Kidney Meeting ...... xt-generation clinical trials.
@nl
P2093
P2860
P50
P356
P1476
The Banff 2017 Kidney Meeting ...... ext-generation clinical trials
@en
P2093
B J Nankivell
C Lefaucheur
Edward S Kraus
Enver Akalin
I W Gibson
J P Duong van Huyen
P2860
P304
P356
10.1111/AJT.14625
P407
P577
2018-01-21T00:00:00Z